These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 27291096)

  • 61. The role of serum procalcitonin in establishing the diagnosis and prognosis of pleural infection.
    Dixon G; Lama-Lopez A; Bintcliffe OJ; Morley AJ; Hooper CE; Maskell NA
    Respir Res; 2017 Feb; 18(1):30. PubMed ID: 28158976
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Head-to-head comparison of procalcitonin and presepsin for the diagnosis of sepsis in critically ill adult patients: a protocol for a systematic review and meta-analysis.
    Hayashida K; Kondo Y; Hara Y; Aihara M; Yamakawa K
    BMJ Open; 2017 Mar; 7(3):e014305. PubMed ID: 28264831
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Soluble CD14 subtype (sCD14-ST) presepsin in premature and full term critically ill newborns with sepsis and SIRS.
    Mussap M; Puxeddu E; Puddu M; Ottonello G; Coghe F; Comite P; Cibecchini F; Fanos V
    Clin Chim Acta; 2015 Dec; 451(Pt A):65-70. PubMed ID: 26232159
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Presepsin as a diagnostic marker of sepsis in children and adolescents: a systemic review and meta-analysis.
    Yoon SH; Kim EH; Kim HY; Ahn JG
    BMC Infect Dis; 2019 Aug; 19(1):760. PubMed ID: 31470804
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Sepsis biomarkers dynamics as an indicator of intensive care effectiveness].
    Zvyagin AA; Demidova VS; Smirnov GV
    Khirurgiia (Mosk); 2019; (2):53-57. PubMed ID: 30855591
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Presepsin: A new marker of catheter related blood stream infections in pediatric patients.
    Tanır Basaranoglu S; Karadag-Oncel E; Aykac K; Ozsurekci Y; Aycan AE; Cengiz AB; Kara A; Ceyhan M
    J Infect Chemother; 2018 Jan; 24(1):25-30. PubMed ID: 28919353
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The diagnostic accuracy of presepsin in neonatal sepsis: a meta-analysis.
    Bellos I; Fitrou G; Pergialiotis V; Thomakos N; Perrea DN; Daskalakis G
    Eur J Pediatr; 2018 May; 177(5):625-632. PubMed ID: 29476345
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Usefulness of presepsin as diagnostic and prognostic marker of sepsis in daily clinical practice.
    Jereb M; Mavric M; Skvarc M; Drobnic A; Dolenc S; Strunjas NP; Luksic B; Kmet NG
    J Infect Dev Ctries; 2019 Nov; 13(11):1038-1044. PubMed ID: 32087076
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Serum Biomarkers for the Early Detection of the Early-Onset Neonatal Sepsis: A Single-Center Prospective Study.
    Ahmed AM; Mohammed AT; Bastawy S; Attalla HA; Yousef AA; Abdelrazek MS; Fransawy Alkomos M; Ghareeb A
    Adv Neonatal Care; 2019 Oct; 19(5):E26-E32. PubMed ID: 31651475
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Elevated Presepsin Levels are Associated with Severity and Prognosis of Severe Acute Pancreatitis.
    Lin J; Li Z; Zheng Y; Zhang Y; Shao C; Liu G; Li J
    Clin Lab; 2016 Sep; 62(9):1699-1708. PubMed ID: 28164588
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Diagnostic accuracy of presepsin (soluble CD14 subtype) for prediction of bacteremia in patients with systemic inflammatory response syndrome in the Emergency Department.
    Romualdo LG; Torrella PE; González MV; Sánchez RJ; Holgado AH; Freire AO; Acebes SR; Otón MD
    Clin Biochem; 2014 May; 47(7-8):505-8. PubMed ID: 24560955
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Presepsin as a potential marker for bacterial infection relapse in critical care patients. A preliminary study.
    Sargentini V; Ceccarelli G; D'Alessandro M; Collepardo D; Morelli A; D'Egidio A; Mariotti S; Nicoletti AM; Evangelista B; D'Ettorre G; Angeloni A; Venditti M; Bachetoni A
    Clin Chem Lab Med; 2015 Mar; 53(4):567-73. PubMed ID: 24897401
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Neutrophil CD64 expression, procalcitonin and presepsin are useful to differentiate infections from flares in SLE patients with SIRS.
    Echeverri A; Naranjo-Escobar J; Posso-Osorio I; Aguirre-Valencia D; Zambrano D; Castaño GL; Martínez JD; Cañas CA; Tobón GJ
    Lupus; 2018 Jun; 27(7):1130-1139. PubMed ID: 29540108
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Presepsin in the prognosis of infectious diseases and diagnosis of infectious disseminated intravascular coagulation: a prospective, multicentre, observational study.
    Takahashi G; Shibata S; Ishikura H; Miura M; Fukui Y; Inoue Y; Endo S
    Eur J Anaesthesiol; 2015 Mar; 32(3):199-206. PubMed ID: 25387303
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparison between presepsin and procalcitonin in early diagnosis of neonatal sepsis.
    Iskandar A; Arthamin MZ; Indriana K; Anshory M; Hur M; Di Somma S;
    J Matern Fetal Neonatal Med; 2019 Dec; 32(23):3903-3908. PubMed ID: 29742943
    [No Abstract]   [Full Text] [Related]  

  • 76. Utility of sTREM-1 and Presepsin (sCD14-ST) as Diagnostic and Prognostic Markers of Sepsis.
    Chen M; Zhu Y
    Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255294
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A Prospective Study of Presepsin as an Indicator of the Severity of Community-Acquired Pneumonia in Emergency Departments: Comparison with Pneumonia Severity Index and CURB-65 Scores.
    Ham JY; Song KE
    Lab Med; 2019 Oct; 50(4):364-369. PubMed ID: 30892617
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Diagnostic and prognostic value of presepsin and procalcitonin in non-infectious organ failure, sepsis, and septic shock: a prospective observational study according to the Sepsis-3 definitions.
    Lee S; Song J; Park DW; Seok H; Ahn S; Kim J; Park J; Cho HJ; Moon S
    BMC Infect Dis; 2022 Jan; 22(1):8. PubMed ID: 34983420
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Diagnostic potential of presepsin in bacterial infection following hepato-biliary-pancreatic surgery: A prospective observational study.
    Yao S; Kaido T; Uozumi R; Hirata M; Iwamura S; Miyachi Y; Macshut M; Sharshar M; Yagi S; Uemoto S
    J Hepatobiliary Pancreat Sci; 2020 Oct; 27(10):756-766. PubMed ID: 32654388
    [TBL] [Abstract][Full Text] [Related]  

  • 80. COMPARISON AMONG PRESEPSIN, PROCALCITONIN, AND C-REACTIVE PROTEIN IN PREDICTING BLOOD CULTURE POSITIVITY AND PATHOGEN IN SEPSIS PATIENTS.
    Xiao H; Zhang H; Wang G; Wang Y; Tan Z; Sun X; Zhou J; Duan M; Zhi D; Hang C; Zhang G; Li Y; Wu C; Zhang H; Xie M; Li C
    Shock; 2024 Mar; 61(3):387-394. PubMed ID: 37878488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.